• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

振动控制瞬时弹性成像和受控衰减参数在非酒精性脂肪性肝病患者肝脂肪变性和肝纤维化诊断中的应用

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.

作者信息

Zenovia Sebastian, Stanciu Carol, Sfarti Catalin, Singeap Ana-Maria, Cojocariu Camelia, Girleanu Irina, Dimache Mihaela, Chiriac Stefan, Muzica Cristina Maria, Nastasa Robert, Huiban Laura, Cuciureanu Tudor, Trifan Anca

机构信息

Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.

St. Spiridon Emergency Hospital, 700115 Iasi, Romania.

出版信息

Diagnostics (Basel). 2021 Apr 27;11(5):787. doi: 10.3390/diagnostics11050787.

DOI:10.3390/diagnostics11050787
PMID:33925569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8146995/
Abstract

Vibration-Controlled Transient Elastography (VCTE) with Controlled Attenuation Parameter (CAP) is a widely used non-invasive technique for concomitant assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the level both of hepatic steatosis and fibrosis as well as the associated risk factors in patients referred to our unit with clinically suspected NAFLD or diagnosed by abdominal ultrasonography. Two hundred four patients were prospectively included in this study and assessed by VCTE with CAP. The final analysis included 181 patients with reliable liver stiffness measurements (LSMs) (53% female, mean age 57.62 ± 11.8 years and BMI 29.48 ± 4.85 kg/m). According to the cut-off values for steatosis grading, there were 10 (5.5%) patients without steatosis (S0), 30 (16.6%) with mild (S1), 45 (24.9%) moderate (S2), and 96 (53%) severe (S3) steatosis. Based on LSM, there were 73 (40.3%) patients without fibrosis (F0), 42 (23.2%) with mild (F1), 32 (17.7%) significant (F2), 19 (10.5%) advanced (F3) fibrosis, and 15 (8.3%) with cirrhosis (F4). In addition, we found an association between several metabolic components and hepatic steatosis and fibrosis. Thus, in the multivariate analysis, higher BMI, fasting plasma glucose, triglycerides, low-density lipoprotein cholesterol, and serum uric were associated with increased CAP. Furthermore, higher serum uric acid and alpha-fetoprotein together with lower platelets count and albumin levels were associated with increased LSM. The assessment of steatosis and fibrosis using VCTE and CAP should be performed in all patients with suspected or previously diagnosed NAFLD in units with available facilities.

摘要

具有受控衰减参数(CAP)的振动控制瞬时弹性成像(VCTE)是一种广泛应用的非侵入性技术,用于同时评估非酒精性脂肪性肝病(NAFLD)患者的肝脏脂肪变性和纤维化。我们旨在评估因临床怀疑NAFLD或经腹部超声诊断而转诊至我科的患者的肝脏脂肪变性和纤维化水平以及相关危险因素。本研究前瞻性纳入了204例患者,并采用VCTE结合CAP进行评估。最终分析纳入了181例肝脏硬度测量值(LSM)可靠的患者(女性占53%,平均年龄57.62±11.8岁,体重指数29.48±4.85kg/m)。根据脂肪变性分级的临界值,无脂肪变性(S0)的患者有10例(5.5%),轻度(S1)的有30例(16.6%),中度(S2)的有45例(24.9%),重度(S3)的有96例(53%)。基于LSM,无纤维化(F0)的患者有73例(40.3%),轻度(F1)的有42例(23.2%),显著(F2)的有32例(17.7%),进展期(F3)的有19例(10.5%),肝硬化(F4)的有15例(8.3%)。此外,我们发现几种代谢成分与肝脏脂肪变性和纤维化之间存在关联。因此,在多变量分析中,较高的体重指数、空腹血糖、甘油三酯、低密度脂蛋白胆固醇和血清尿酸与CAP升高有关。此外,较高的血清尿酸和甲胎蛋白,以及较低的血小板计数和白蛋白水平与LSM升高有关。对于所有疑似或先前诊断为NAFLD且所在科室具备可用设备的患者,均应采用VCTE和CAP对脂肪变性和纤维化进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/bc7febf4c192/diagnostics-11-00787-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/9273b77d8e07/diagnostics-11-00787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/a513a3867b10/diagnostics-11-00787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/bc7febf4c192/diagnostics-11-00787-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/9273b77d8e07/diagnostics-11-00787-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/a513a3867b10/diagnostics-11-00787-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d3d/8146995/bc7febf4c192/diagnostics-11-00787-g003.jpg

相似文献

1
Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.振动控制瞬时弹性成像和受控衰减参数在非酒精性脂肪性肝病患者肝脂肪变性和肝纤维化诊断中的应用
Diagnostics (Basel). 2021 Apr 27;11(5):787. doi: 10.3390/diagnostics11050787.
2
The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.通过振动控制瞬时弹性成像和受控衰减参数评估罗马尼亚健康医学生的肝脂肪变性和纤维化患病率
Diagnostics (Basel). 2021 Dec 13;11(12):2341. doi: 10.3390/diagnostics11122341.
3
Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter.使用具有受控衰减参数的振动控制瞬时弹性成像技术同时筛查罗马尼亚2型糖尿病患者的肝脂肪变性和肝纤维化
Diagnostics (Basel). 2022 Jul 20;12(7):1753. doi: 10.3390/diagnostics12071753.
4
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis.控制衰减参数(CAP)和肝脏硬度测量(LSM)评估非酒精性脂肪性肝病中脂肪变性和纤维化的准确性:一项系统评价和荟萃分析。
EClinicalMedicine. 2022 Jul 10;51:101547. doi: 10.1016/j.eclinm.2022.101547. eCollection 2022 Sep.
5
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
6
Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.在单中心真实世界经验中,使用振动控制瞬时弹性成像和受控衰减参数对大量2型糖尿病患者进行肝纤维化和脂肪变性筛查
J Clin Med. 2020 Apr 6;9(4):1032. doi: 10.3390/jcm9041032.
7
Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.瞬时弹性成像(fibroscan)的实用性和减重手术对病态肥胖患者非酒精性脂肪性肝病(NAFLD)的影响。
Surg Obes Relat Dis. 2018 Jan;14(1):81-91. doi: 10.1016/j.soard.2017.09.005. Epub 2017 Sep 11.
8
Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD.用于评估非酒精性脂肪性肝病(NAFLD)中肝脂肪变性和纤维化的受控衰减参数瞬时弹性成像与二维剪切波弹性成像及衰减成像的比较
Ultrasonography. 2023 Jul;42(3):421-431. doi: 10.14366/usg.22212. Epub 2023 Mar 22.
9
Assessment of Predictive Factors of Hepatic Steatosis Diagnosed by Vibration Controlled Transient Elastography (VCTE) in Chronic Hepatitis C Virus-Infected Patients.慢性丙型肝炎病毒感染患者中通过振动控制瞬时弹性成像(VCTE)诊断肝脂肪变性的预测因素评估
J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):58-65. doi: 10.55729/2000-9666.1071. eCollection 2022.
10
Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.中重度肝脂肪变可导致慢性乙型肝炎无显著纤维化患者肝硬度测量值偏高。
Aliment Pharmacol Ther. 2019 Jul;50(1):93-102. doi: 10.1111/apt.15298. Epub 2019 May 16.

引用本文的文献

1
Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with psoriasis: A cross-sectional study.振动控制瞬时弹性成像技术用于土耳其银屑病患者肝纤维化和脂肪变性的无创筛查:一项横断面研究。
Hepatol Forum. 2024 Jan 16;5(1):29-32. doi: 10.14744/hf.2023.2023.0017. eCollection 2024.
2
Allopurinol versus Febuxostat: A New Approach for the Management of Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.别嘌醇与非布司他:代谢功能障碍相关脂肪性肝病肝脂肪变性管理的新方法。
Biomedicines. 2023 Nov 16;11(11):3074. doi: 10.3390/biomedicines11113074.
3

本文引用的文献

1
Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East.接受Fibroscan检查患者的肝脏疾病谱:中东地区的单中心经验
Ann Med Surg (Lond). 2020 Jul 25;57:166-170. doi: 10.1016/j.amsu.2020.07.040. eCollection 2020 Sep.
2
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.代谢风险因素与非酒精性脂肪性肝病(NAFLD)患者发生进展性肝疾病的关系:基于人群的观察性研究的系统评价和荟萃分析。
PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr.
3
Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease.
非酒精性脂肪性肝病相关肝细胞癌管理中的挑战与解决方案
Life (Basel). 2023 Sep 29;13(10):1987. doi: 10.3390/life13101987.
4
Prediction of Liver Steatosis and Fibrosis Based on Clinical Variables Using a Large National Survey Database.基于大型全国调查数据库的临床变量预测肝脂肪变性和纤维化。
Can J Gastroenterol Hepatol. 2023 May 24;2023:1791500. doi: 10.1155/2023/1791500. eCollection 2023.
5
Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter.使用具有受控衰减参数的振动控制瞬时弹性成像技术对炎症性肠病患者进行肝脂肪变性和纤维化筛查。
J Clin Med. 2022 Oct 9;11(19):5959. doi: 10.3390/jcm11195959.
6
Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile.蓝藻增强了接受核苷(酸)类似物治疗的慢性乙型肝炎患者的血清学转换,通过调节 TNF-α/IFN-γ 谱。
Nutrients. 2022 Jul 6;14(14):2790. doi: 10.3390/nu14142790.
Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980-2018.
非酒精性脂肪性肝炎:1980 - 2018年出版物的科学计量分析
Medicine (Baltimore). 2019 Dec;98(50):e18221. doi: 10.1097/MD.0000000000018221.
4
Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study.使用 FibroScan M/XL 探头测量肝脏硬度和受控衰减参数诊断非酒精性脂肪性肝病患者肝纤维化和脂肪变性的准确性:一项多中心前瞻性研究。
J Gastroenterol. 2020 Apr;55(4):428-440. doi: 10.1007/s00535-019-01635-0. Epub 2019 Oct 25.
5
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis.非肝硬化非酒精性脂肪性肝病患者肝细胞癌的特征和结局。
Liver Int. 2019 Jun;39(6):1098-1108. doi: 10.1111/liv.14087. Epub 2019 Mar 29.
6
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).血清尿酸水平升高影响非酒精性脂肪性肝病(NAFLD)患者的肝损伤。
Rev Esp Enferm Dig. 2019 Apr;111(4):264-269. doi: 10.17235/reed.2019.5965/2018.
7
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.肝纤维化无创诊断技术评估非酒精性脂肪性肝病患者肝脏脂肪变及纤维化的准确性。
Gastroenterology. 2019 May;156(6):1717-1730. doi: 10.1053/j.gastro.2019.01.042. Epub 2019 Jan 25.
8
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.
9
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.振动控制瞬时弹性成像评估非酒精性脂肪性肝病患者的纤维化和脂肪变性。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26.
10
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease.用于评估非酒精性脂肪性肝病的振动控制瞬时弹性成像的性能特征
Hepatology. 2018 Jan;67(1):134-144. doi: 10.1002/hep.29489. Epub 2017 Nov 29.